From: theniklank@gmail.com   
      
   According to a recent study published in the Diabetes Care journal, adding   
   dapagliflozin to sitagliptin monotherapy reduces blood glucose levels in   
   patients with type 2 diabetes.   
      
   People suffering from type 2 diabetes may sometimes require multiple   
   therapies/combination therapy to manage their blood glucose levels. Dipeptidyl   
   peptidase-4 (DPP-4) inhibitors are one of the most widely prescribed therapies   
   used in combination with    
   eithermetformin or sulfonylureas.   
      
   Read More Visit: https://www.icontrolmyhealth.org/news/combinati   
   n-therapy-for-diabetes   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)